主要学术成果 |
代表性论文:(加“*”为通讯作者) |
1 | Lv S,Ye M,Wang X,Li Z,Chen X,Dou X,Dai Y,Zeng F,Luo L,Wang C,Li K,Luo X,Yan J*,Li X.A recombined fusion protein SP5.2/tTF induce thrombosis in tumor blood vessel Neoplasma, 62(4):531-540,2015 |
2 | Yang Y,Chen N,Li Z,Wang XJ,Wang SY,Wu T, Luo FH,Yan JH*.Preparation, Purification, and Identification of a Monoclonal Antibody Against NRP2 b1b2 Domain.Monoclonal antibodies in immunodiagnosis and immunotherapy, 34(5): 354-359,2015 |
3 | Zeng FW, Luo FH, Lv S, Zhang HP, Cao C, Chen XL, Wang SY, Li Z, Wang XJ, Dou XF, Dai YJ, He MJ, Zhang YF, Lv HY, Yan JH*, Chen YQ. A monoclonal antibody targeting neuropilin-1 inhibits adhesion of MCF7 breast cancer cells to fibronectin by suppressing the FAK/p130cas signaling pathway. Anti-cancer drugs, 25(6): 663-672,2014 |
4 | Lukui Chen, Wei Miao, Xiaoyong Tang, Haipeng Zhang,Shengyu Wang, Fanghong Luo, and Jianghua Yan*.The expression and significance of neuropilin-1(NRP-1) on the glioma cell lines tissues, Journal of Biomedical Nanotechnology. 9(4):559–563, 2013 |
5 | Wu na, Wang yongjun, Wang shengyu, Chen yuqiang, Yan jianghua*. Recombinant human leptin induces growth inhibition and apoptosis in human gastric cancer MGC-803 cells, Clinical And Experimental Medicine, 4(13): 305-314, 2013 |
6 | Chen xiaoli, Lv haiyan,Ye min,Wang shengyu,Ni eru,Zeng fanwei,Cao chang, Luofanghong, Yan jianghua*, Novel superparamagnetic iron oxide nanoparticles for tumor embolization application: preparation, characterization and double targeting, International Journal of Pharmaceutics,426:248-255, 2012 |
7 | Zeng Fanwei,Ni Erru,Wang Shengyu,Lv Sha, Cao Chang, Zhang Haipeng, Lv Haiyan, Chen Xiaoli, Yan Jianghua*,and Luo Fanghong*,Monoclonal Antibody against Catalytic Domain of PTP1B,Hybridoma,31(3):209-213,2012 |
8 | Li Xiang,luo Fanghong,Wang Shengyu,Ni Erru,Tang Xiaoyong,Lv Haiyan,Chen X iaoli,Chen Lukui,Yan Jianghua*,Monoclonal Antibody Against NRP1 b1b2,Hybridoma,30:369-373,2011 |
9 | Xie lianying,Wang yongjun,Wang shengyu,WuNa,Chen yuqiang*,Yan jianghua*,Adiponectin induces growth inhibition and apoptosis in cervical cancer HeLa cells,Biologia, 4(66):712-720,2011 |
10 | He Kangxia, He Jie,Wang Shengyu, Yan Jianghua*, hSHIP induces S-phase arrest and growth inhibition in cervical cancer HeLa cells,Journal of Genetics And Genomics, 37(4):249-255,2010 |
专利: |
1 | 颜江华,王生育,罗芳洪,吴婷,倪二茹,王勇军,抗人神经纤毛蛋白1的单域抗体及其制备方法,申请日:2015.11.10,中国,专利号:201510757571.4 |
2 | 颜江华,王生育,罗芳洪,吴婷,王勇军,一种葡聚糖的夹心酶联免疫吸附测定方法,申请日:2015.8.20,中国,专利号:201510513781.9 |
3 | 颜江华,何杰,李响,王生育。肿瘤血管靶向多肽与组织因子的融合蛋白及其制备方法。授权日:2012.8.15,中国,专利号:201010616867.1 |
4 | 颜江华,曾练强,王生育,倪二茹,梁达奉。抗葡聚糖单链抗体及其制备方法。授权日:2012.11.14,中国,专利号:201110023901 |
主持课题: |
1 | 外周血细胞膜抗体库的建立,横向课题,100万元,2015.5-2017.7 |
2 | 抗NRP-1b1/b2单克隆抗体抗肿瘤活性与分子机制,国家自然科学基金,50万元,2012.1-2015.12 |
3 | 新型肿瘤血管栓塞体系的建立及其抗肿瘤活性,国家自然科学基金,28万元,2010.1-2012.12 |
4 | 免疫细胞治疗技术与应用,横向课题,500万元,2007.8-2011.8 |
5 | 一组肿瘤相关单克隆抗体的研制与初步临床应用研究,福建省科技重点项目,30万元2014.1-2016.12 |
获奖: |
1 | 大剂量国产胸腺肽联合干扰素治疗慢性乙肝及其机理。获2000年厦门市科技成果三等奖(第二作者)。 |
2 | 抗人肝癌单克隆抗体的导向治疗研究。获1996年福建省卫生厅科技成果二等奖.(第一作者) |